
We will address health and welfare with a focus on reducing Antimicrobial Resistance (AMR), and continue to innovate so that we can deliver new products and services that directly minimise dependency on antibiotic usage. We will adopt five-steps targets that will significantly reduce antibiotic usage by creating business opportunities for our customers.